Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

Affiliations

¹ Department of Hematology and Oncology, Ulsan University Hospital, Bangeojinsunhwando-ro, Dong-gu, Ulsan, 877, Korea. sujinkoh@uuh.ulsan.kr.
² Department of Breast Oncology, NHO Shikoku Cancer Center, Ehime, Japan.
³ Department of Breast Surgery, NHO Hokkaido Cancer Center, Hokkaido, Japan.
⁴ Breast Center, Kameda Medical Center, Chiba, Japan.
⁵ Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
⁶ Department of Breast and Endocrine Surgical Oncology, Tohoku University Hospital, Miyagi, Japan.
⁷ Tri-Service General Hospital, Taipei, Taiwan.
⁸ Cheng Hsin General Hospital, Taipei, Taiwan.
⁹ AstraZeneca Pharmaceuticals, Gaithersburg, USA.
¹⁰ AstraZeneca, Cambridge, UK.
¹¹ Baylor Charles A. Sammons Cancer Center, Texas, USA.
¹² Hospital Universitari Vall d'Hebron, Barcelona, Cataluña, Spain.

Published Erratum

Su-Jin Koh et al. Breast Cancer. 2022 Jan.

. 2022 Jan;29(1):189-190.

doi: 10.1007/s12282-021-01299-w.

¹ Department of Hematology and Oncology, Ulsan University Hospital, Bangeojinsunhwando-ro, Dong-gu, Ulsan, 877, Korea. sujinkoh@uuh.ulsan.kr.
² Department of Breast Oncology, NHO Shikoku Cancer Center, Ehime, Japan.
³ Department of Breast Surgery, NHO Hokkaido Cancer Center, Hokkaido, Japan.
⁴ Breast Center, Kameda Medical Center, Chiba, Japan.
⁵ Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
⁶ Department of Breast and Endocrine Surgical Oncology, Tohoku University Hospital, Miyagi, Japan.
⁷ Tri-Service General Hospital, Taipei, Taiwan.
⁸ Cheng Hsin General Hospital, Taipei, Taiwan.
⁹ AstraZeneca Pharmaceuticals, Gaithersburg, USA.
¹⁰ AstraZeneca, Cambridge, UK.
¹¹ Baylor Charles A. Sammons Cancer Center, Texas, USA.
¹² Hospital Universitari Vall d'Hebron, Barcelona, Cataluña, Spain.

No abstract available

Erratum for

Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study.
Koh SJ, Ohsumi S, Takahashi M, Fukuma E, Jung KH, Ishida T, Dai MS, Chang CH, Dalvi T, Walker G, Bennett J, O'Shaughnessy J, Balmaña J. Koh SJ, et al. Breast Cancer. 2022 Jan;29(1):92-102. doi: 10.1007/s12282-021-01283-4. Epub 2021 Aug 31. Breast Cancer. 2022. PMID: 34467476 Free PMC article.